Now I have enough information. Let me write the consolidated review.

## Summary

The paper introduces Constrained Mass Transport (CMT), a variational framework for constructing annealing paths between a tractable prior and an unnormalized target density by jointly constraining the KL divergence (trust-region) and entropy decay between successive intermediate distributions. The framework is instantiated with normalizing flows and evaluated on molecular Boltzmann generator benchmarks up to dimension 219 (the newly introduced ELIL tetrapeptide), where CMT consistently achieves the best effective sample size, evidence upper bound, and Ramachandran total variation distance across all systems.

## Strengths

1. **Novel and well-motivated combination of constraints.** The idea of jointly enforcing both a trust-region bound and an entropy-decay bound on successive intermediate densities is conceptually clean and practically effective. The ablation study (Figures 2–3) provides direct causal evidence that both constraints together are necessary: using either alone leads to mode collapse or instability on alanine hexapeptide, while the combined constraint avoids both.

2. **Consistent state-of-the-art empirical results across multiple molecular systems.** Table 1 shows CMT achieves the highest ESS on all four benchmarks (e.g., 97.69% vs 95.76% for TA-BG on alanine dipeptide, 29.63% vs 18.22% on alanine hexapeptide, 26.06% vs 13.75% on ELIL tetrapeptide) and the best EUBO on every system, using comparable or fewer target evaluations. The trends are consistent across systems and metrics, not cherry-picked from a single favorable setting.

3. **Largest molecular system studied without molecular dynamics samples.** The ELIL tetrapeptide (d=219) is a genuine extension of the benchmark frontier. That reverse KL collapses to 1.26% ESS while CMT achieves 26.06% on this system is a meaningful demonstration of robustness to higher dimensionality and more complex side-chain interactions.

4. **Negligible overhead for constraint enforcement.** The paper reports (Appendix D.4) that the dual optimization accounts for ~0.01% of total training time on alanine dipeptide. This makes the theoretical benefits of the constraints essentially free in practice.

## Weaknesses

### Fatal
None.

### Major

1. **Incorrect exponents in Propositions 2.1 and 2.3 (exposition error).** The Lagrangian in (3) is ℒ = D_KL(q‖p) + λ(D_KL(q‖q_i) − ε_tr). Minimising over q gives q_{i+1} ∝ q_i^{λ/(1+λ)} p̃^{1/(1+λ)}. However, Proposition 2.1 writes both exponents as 1/(1+λ), which is mathematically incorrect. The same error recurs in Proposition 2.3: the correct form is q ∝ q_i^{λ/(1+λ+η)} p̃^{1/(1+λ+η)}, but the paper writes both exponents as 1/(1+λ+η).  

   Crucially, this is an **exposition error, not an algorithmic error** — the parts of the paper that actually implement the method are correct. Theorem 2.4 states the correct annealing-path forms (q_i ∝ q_0^{1−β_i} p̃^{β_i} and q_i ∝ q_0^{1−β_i}(p̃^{α_i})^{β_i}), and equation (16), used in the dual optimization, computes the normalization constant using the correct formula (deriving from q_i^{λ/(1+λ+η)} p̃^{1/(1+λ+η)}, not the stated Proposition 2.3). The algorithm as implemented is therefore sound. Nevertheless, the paper as written contains a wrong derivation in its central theoretical section, which is a serious presentation flaw that must be corrected before the paper can be considered reliable.

2. **The headline "more than 2.5× higher ESS" is selectively reported.** Comparing CMT to the *best* baseline (TA-BG) on each system gives ratios of ~1.02× (alanine dipeptide), ~1.04× (alanine tetrapeptide), ~1.63× (alanine hexapeptide), and ~1.89× (ELIL tetrapeptide). The 2.5× figure is only achieved against weaker baselines (e.g., FAB on ELIL gives 3.6×). While the claim is not false if interpreted loosely, it exaggerates the practical advantage over the strongest competitors. The authors should qualify this claim or re-baseline against the best alternative.

### Minor

1. **Wall-clock cost and gradient-update count are not reported.** The paper only reports "target evaluations" as a cost metric. Because CMT's dual optimization and importance-weighted forward KL update require multiple passes through the buffer, the total training time may be higher than simpler baselines such as reverse KL. The authors acknowledge this as a limitation in the conclusion but do not quantify it. A comparison of gradient updates or wall-clock time on at least one system would allow readers to assess the efficiency trade-off.

2. **Sensitivity to hyperparameters ε_tr and ε_ent is only studied on one system.** The ablation on alanine hexapeptide is informative, but practitioners would benefit from knowing how these bounds should be set across different dimensionalities and energy landscapes.

### Trivial
None.

## Nice-to-Haves
- A plot showing how the learned multipliers (β_i, α_i) evolve over steps for different systems would visually illustrate the automatic schedule tuning.
- A quick experiment applying CMT in Cartesian coordinates (as the conclusion suggests as future work) on alanine dipeptide would strengthen the generality claim.

## Removed Points

- **Criticism about "the method does not implement the claimed constrained mass transport" due to the exponent error** (from Harsh Critic, Critical Issue 1, second paragraph): REMOVED as verified incorrect — the algorithm (eq 16) and Theorem 2.4 use the correct form. The error is confined to the Proposition statements and does not affect the implementation. The criticism incorrectly elevates an exposition error to a fatal structural flaw.
- **"Mass teleportation definition differs from prior work"** (Section-by-Section Notes): REMOVED — the paper explicitly clarifies its definition and distinguishes it from Máté & Fleuret's usage (lines 35–36). This is not a weakness.
- **"Missing Appendix/Appendix-dependent content"** criticisms: REMOVED — per the meta-reviewer instructions, appendix sections are stripped by the parser for all papers; these are not author omissions.
- **Strength about "novel combination of constraints leading to principled and effective annealing path"** (from Strength Finder): MODIFIED and kept — the core idea is novel and effective, but the "principled" aspect is undermined by the Proposition exponent errors. The strength is retained with qualification.
- **Strength about "open-source code and ground-truth data"**: KEPT — this is concrete and verified.
- **Strength about "variance control via trust-region constraint improves scalability"**: KEPT but downgraded — the theoretical argument in Appendix C.3 is plausible but the appendix is stripped from the extract, so the empirical support (Table 1 trends) is the main evidence.

## Novel Insights

The most interesting observation that emerges from combining the reviews is the *internal inconsistency* in the paper's theoretical exposition: the Propositions are wrong, but the dual optimization (eq 16) and Theorem 2.4 are correct, and the algorithm is therefore correct. This suggests the error is a copy-paste or transcription mistake in writing the exponents, not a conceptual misunderstanding. The paper would benefit from a clear errata table. A second insight is that the relative improvement of CMT over baselines grows sharply with dimensionality (from ~2% on d=60 to ~63–89% on d=180–219), which suggests the joint constraint becomes increasingly important as the target becomes more complex — a finding the paper could emphasize more explicitly.

## Suggestions

1. **Fix the exponents in Propositions 2.1 and 2.3.** Proposition 2.1 should read q_{i+1} ∝ q_i^{λ/(1+λ)} p̃^{1/(1+λ)}, and Proposition 2.3 should read q_{i+1} ∝ q_i^{λ/(1+λ+η)} p̃^{1/(1+λ+η)}. Verify that all downstream references to these formulas are consistent.

2. **Qualify the "2.5×" claim** by stating which baseline it refers to (or, better, report improvement over the best baseline as the primary comparison).

3. **Add a wall-clock time or gradient-update comparison** for at least the largest system to help readers assess the computational overhead.

4. **Add a hyperparameter sensitivity study** for ε_tr and ε_ent across multiple systems.

## Score and Decision

**Calibration anchors** (from retrieval batch; listed for transparency):

| Path | Avg Score | Comparison |
|------|-----------|------------|
| NSVtmmzeRB (GeoBFN, 3D molecules) | 8.00 | Stronger paper: cleaner theory, broader scope. Current paper is narrower but has comparable empirical rigor. |
| DZcmz9wU0i (Geometric Tempering theory) | 7.00 | Stronger theory, no experiments on real molecular systems. Current paper has weaker theory but stronger experiments. |
| pRCOZllZdT (BoPITO, Boltzmann priors) | 7.00 | Comparable methodological novelty; current paper tests on larger systems. |
| TUvg5uwdeG (Neural Sampling from Boltzmann Densities) | 6.40 | Similar tradeoff: modest theory + experiments. Current paper's experiments are more extensive. |
| ybWOYIuFl6 (BNEM, Boltzmann sampler) | 6.00 | Current paper tests more systems at larger scale. BNEM's theory is cleaner. The papers are comparable in overall quality. |
| CkozFajtKq (LiFlow, flow matching) | 6.33 | Different domain (crystal MD acceleration), but both are applied ML for science papers. Current paper has clearer contribution framing. |
| XcAJ0qsMgh (Annealing Flow) | 3.60 | Weaker paper: limited evaluation, missing details. Current paper is substantially stronger. |
| XWfjugkXzN (low-score anchor) | 1.67 | Not comparable (different problem domain). |

The paper presents a genuinely novel framework (joint trust-region + entropy constraints) with strong and consistent empirical results on challenging molecular benchmarks, including a new largest system. However, the theoretical exposition in Propositions 2.1 and 2.3 contains mathematically incorrect exponents, which is a significant presentation flaw — even though the algorithm itself (Theorem 2.4 and eq. 16) is correctly specified. Relative to the calibration anchors, the paper is stronger than typical rejection-range papers (3–4) but has a clearer flaw than top-scoring papers (7–8). It sits in the 5.5–6.5 band: the contributions are real and the empirical evidence is compelling, but the mathematical error must be corrected.

**Score:** 6.0  
**Decision:** Accept

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>